CellFacts Instruments Limited
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
CellFacts Instruments Limited - overview
Established
2001
Location
Coventry, -, UK
Primary Industry
Consumer Products
About
CellFacts Instruments Limited is a domain name sales and leasing company, focusing on facilitating secure transactions for clients seeking to establish a robust online presence through premium domain acquisitions. CellFacts Instruments Limited, founded in 2001 and headquartered in Coventry, UK, specializes in domain name sales and leasing. The company has remained dedicated to its core business model without significant pivots. Crawford Dow serves as the CEO.
In April 2011, the company secured GBP 230,000 in financing from Blue Sky Capital and Midven, valuing the company at GBP 0. 45 million post-money. It has completed a total of 1 deal since inception. CellFacts.
com specializes in the sale and leasing of domain names, focusing on the domain name CellFacts. com, which is currently available for purchase. The company ensures secure and hassle-free transactions, catering primarily to startups and established businesses across North America and Europe. This model enhances the user experience by providing secure payment options and customer support throughout the transaction process.
In the most recent fiscal year, CellFacts Instruments Limited generated revenue of GBP 391,190. 90. The company’s pricing structure for domain sales is straightforward, with the CellFacts. com domain priced at GBP 690, allowing both individual clients and businesses to purchase domain names directly, ensuring a consistent revenue stream.
CellFacts Instruments Limited plans to leverage the recent financing of GBP 230,000, completed in April 2011, to enhance its product offerings and expand into new geographic markets. The company is focusing on developing new domain name products intended for launch in the upcoming fiscal year. Additionally, it is targeting expansion into markets beyond North America and Europe, aiming for a global customer base by the end of 2012.
Current Investors
Future Planet Capital Regional, Blue Sky Capital
Primary Industry
Consumer Products
Sub Industries
Consumer Electronics
Website
www.cellfacts.com
Verticals
Manufacturing
Company Stage
Early Stage
Total Amount Raised
Subscriber access only
CellFacts Instruments Limited - financials
| Fiscal Year Ended | Dec 31, 2002 | Dec 31, 2003 | Dec 31, 2004 | Dec 31, 2005 | Dec 31, 2006 | Dec 31, 2007 |
|---|---|---|---|---|---|---|
| Revenue (USD) | 321,759 | 239,241 | - | - | - | - |
| % Revenue Growth (YoY) | - | (25.6%) | - | - | - | - |
| EBITDA (USD) | (84,481) | (63,102) | - | - | - | - |
| Operating Income (USD) | (90,981) | (69,602) | - | - | - | - |
| Operating Margin | (28.3%) | (29.1%) | - | - | - | - |
| % EBITDA Margin | (26.3%) | (26.4%) | - | - | - | - |
| NET Income (USD) | (91,178) | (69,737) | - | - | - | - |
| % Net Margin | (28.3%) | (29.1%) | - | - | - | - |
CellFacts Instruments Limited - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.